DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Calicheamicin

Calicheamicin

  • C-1027, a Radiomimetic Enediyne Anticancer Drug, Preferentially Targets Hypoxic Cells

    C-1027, a Radiomimetic Enediyne Anticancer Drug, Preferentially Targets Hypoxic Cells

  • Enediynes, Enyneallenes, Their Reactions, and Beyond

    Enediynes, Enyneallenes, Their Reactions, and Beyond

  • Inotuzumab Ozogamicin Is an Investigational Agent and Has Not Been Approved for Marketing by Any Regulatory Agency at This Time

    Inotuzumab Ozogamicin Is an Investigational Agent and Has Not Been Approved for Marketing by Any Regulatory Agency at This Time

  • Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin

    Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin

  • The Novel Calicheamicin-Conjugated CD22 Antibody Inotuzumab Ozogamicin (CMC-544) Effectively Kills Primary Pediatric Acute Lymphoblastic Leukemia Cells

    The Novel Calicheamicin-Conjugated CD22 Antibody Inotuzumab Ozogamicin (CMC-544) Effectively Kills Primary Pediatric Acute Lymphoblastic Leukemia Cells

  • Total Synthesis of Calicheamicin Type Enediyne Natural Products

    Total Synthesis of Calicheamicin Type Enediyne Natural Products

  • Functional and Structural Characterization of the Proteins from Early Steps of Calicheamicin Biosynthesis

    Functional and Structural Characterization of the Proteins from Early Steps of Calicheamicin Biosynthesis

  • Antibody–Drug Conjugates for Cancer Therapy

    Antibody–Drug Conjugates for Cancer Therapy

  • The Chemistry of Nine-Membered Enediyne Natural Products

    The Chemistry of Nine-Membered Enediyne Natural Products

  • Developments and Challenges for Mab-Based Therapeutics

    Developments and Challenges for Mab-Based Therapeutics

  • Transcriptional Effects of the Potent Enediyne Anti-Cancer Agent

    Transcriptional Effects of the Potent Enediyne Anti-Cancer Agent

  • Population Pharmacokinetics of Inotuzumab Ozogamicin in Relapsed/ Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma

    Population Pharmacokinetics of Inotuzumab Ozogamicin in Relapsed/ Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma

  • Assessment of Clinical Immunogenicity of Inotuzumab Ozogamicin In

    Assessment of Clinical Immunogenicity of Inotuzumab Ozogamicin In

  • Enediyne Natural Products: Biosynthesis and Prospect Towards Engineering Novel Antitumor Agents

    Enediyne Natural Products: Biosynthesis and Prospect Towards Engineering Novel Antitumor Agents

  • Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications

    Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications

  • Kedarcidin Chromophore: an Enediyne That Cleaves DNA in a Sequence-Specific Manner N

    Kedarcidin Chromophore: an Enediyne That Cleaves DNA in a Sequence-Specific Manner N

  • Mylotarg, INN-Gemtuzumab Ozogamicin

    Mylotarg, INN-Gemtuzumab Ozogamicin

  • Kedarcidin Chromophore: an Enediyne That Cleaves DNA in a Sequence-Specific Manner N

    Kedarcidin Chromophore: an Enediyne That Cleaves DNA in a Sequence-Specific Manner N

Top View
  • A New Class of Antibody-Drug Conjugates with Potent DNA Alkylating
  • MYLOTARG (Gemtuzumab Ozogamicin)
  • Single Chemical Modifications of the C-1027 Enediyne Core, A
  • Immunotoxins and Anticancer Drug Conjugate Assemblies: the Role of the Linkage Between Components
  • Synthetic Approaches to Fluorinated Ten-Membered Enediyne
  • Complete Set of Glycosyltransferase Structures in the Calicheamicin Biosynthetic Pathway Reveals the Origin of Regiospecificity
  • The Reactivity of Calicheamicin [Gamma]1I in the Minor Groove Of
  • Review Chemistry and Biology of Natural and Designed Enediynes K
  • Selective Proteolytic Activity of the Antitumor Agent Kedarcidin N
  • Antibody-Drug Conjugates: the New Frontier of Chemotherapy
  • E Speramicin- a Cytotoxic Antitumor Antibiotic
  • Salvage Chemoimmunotherapy with Inotuzumab Ozogamicin Combined
  • Clinical Pharmacology Biopharmaceutics Review(S)
  • Comparison of Antibiotic Resistance Mechanisms in Antibiotic-Producing and Pathogenic Bacteria
  • Polyketide Synthase Chemistry Does Not Direct Biosynthetic Divergence Between 9- and 10-Membered Enediynes
  • 761040Orig1s000
  • Crystal Structure of O-Methyltransferase Calo6 from the Calicheamicin Biosynthetic Pathway: a Case of Challenging Structure Determination at Low Resolution Oleg V
  • CMC-544 (Inotuzumab Ozogamicin): a CD22-Targeted Immunoconjugate


© 2024 Docslib.org    Feedback